Evaluation of a Virus Neutralisation Test for Detection of Rift Valley Fever Antibodies in Suid Sera.
ELISA and VNT
Rift Valley fever
Rift Valley fever virus
domestic pig
inter-epidemic period
Journal
Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042
Informations de publication
Date de publication:
25 Mar 2019
25 Mar 2019
Historique:
received:
08
02
2019
revised:
16
03
2019
accepted:
19
03
2019
entrez:
3
4
2019
pubmed:
3
4
2019
medline:
3
4
2019
Statut:
epublish
Résumé
Rift Valley fever (RVF) is a vector-borne viral disease of ruminants mainly, and man, characterized by abortions and neonatal deaths in animals and flu-like to more severe symptoms that can result in death in humans. The disease is endemic in Africa, Saudi Arabia and Yemen, and outbreaks occur following proliferation of RVF virus (RVFV) infected mosquito vectors. Vertebrate animal maintenance hosts of RVFV, which serve as a source of virus during inter-epidemic periods remain unknown, with wild and domestic suids being largely overlooked. To address this, we evaluated the virus neutralization test (VNT) for RVF antibody detection in suid sera, as a first step in assessing the role of suids in the epidemiology of RVF in Africa. Testing of experimental and field sera from domestic pigs and warthogs with a commercial RVF competitive antibody ELISA, served as a reference standard against which the VNT results were compared. Results indicate that VNT can detect anti-RVFV antibodies within three days post-infection, has an analytical specificity of 100% and diagnostic sensitivity and specificity of 80% and 97%, respectively. Although labour-intensive and time-consuming, the VNT proved suitable for screening suid sera and plasma for presence of RVFV antibodies in viraemic and recovered animals.
Identifiants
pubmed: 30934604
pii: tropicalmed4010052
doi: 10.3390/tropicalmed4010052
pmc: PMC6473580
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Indian J Med Microbiol. 2017 Apr-Jun;35(2):184-193
pubmed: 28681804
PLoS One. 2015 Nov 13;10(11):e0142129
pubmed: 26566248
J Vis Exp. 2014 Nov 04;(93):e52065
pubmed: 25407402
Viruses. 2023 Feb 16;15(2):
pubmed: 36851759
Arch Virol. 2018 Aug;163(8):2295-2310
pubmed: 29680923
J Hyg (Lond). 1985 Aug;95(1):197-209
pubmed: 2862206
J Virol Methods. 2011 Nov;177(2):140-6
pubmed: 21827790
Vet Res. 2010 Nov-Dec;41(6):61
pubmed: 21188836
Trends Microbiol. 2012 Jan;20(1):50-7
pubmed: 22153753
J Virol Methods. 2013 Jan;187(1):177-81
pubmed: 23022325
Viruses. 2011 May;3(5):493-519
pubmed: 21666766
Vet Res. 2013 Sep 09;44:78
pubmed: 24016237
BMC Vet Res. 2017 Apr 5;13(1):87
pubmed: 28381251
Nature. 1963 Nov 30;200:919-20
pubmed: 14096097
Ann Trop Paediatr. 2006 Sep;26(3):251-3
pubmed: 16925964
Vector Borne Zoonotic Dis. 2017 May;17(5):358-360
pubmed: 28437185
J S Afr Vet Assoc. 1980 Sep;51(3):153-7
pubmed: 6267276
J Gen Virol. 2017 May;98(5):875-887
pubmed: 28555542
Clin Vaccine Immunol. 2014 Oct;21(10):1460-2
pubmed: 25100824
J Med Virol. 2008 May;80(5):929
pubmed: 18360907
Transbound Emerg Dis. 2018 Feb;65(1):e55-e62
pubmed: 28710814